Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
AMG 706 + Gemcitabine for Cancer
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing the effects of a new drug, AMG 706, when given with gemcitabine to patients with advanced solid tumors or lymphoma. The purpose is to study the side effects and what dose is best.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.